Andreas von Deimling

Andreas von Deimling; Prof. Dr.

Heidelberg, GERMANY

Professional experience

Year(s)

Education

Since 2007

Head Department of Neuropathology, University Heidelberg, and, Head Clinical Cooperation Unit Neuropathology, DKFZ

1999-2006

Head Department of Neuropathology, Charité, Berlin

1994-1998

Consultant, Neuropathology, University Bonn,

1994

Board certification for Neuropathology

1992-1994

Resident, Neuropathology, University Bonn,

1990-1992

Postdoc, Mass. Gen, Hospital / Harvard Medical School,USA, Neurogenetics

1988-1990

Resident, Neuropathology, University Zurich, Switzerland,

Selected Patents

  1. Molecular classification for personalized treatment of central nervous system malignancies: pending
  2. Biochemical detection of 2-hydroxyglutarate: EP 2820145
  3. BRAF VE1 antibody:
  4. IDH H09antibody: EPA 09006620

 

MiscellanEous

Year(s)

 

1983 - 1988

Scholar of the German National Scholarship Foundation

1995

Schäfersnolte Award (State Nordrhein-Westfalen)

1995-1998

Hermann and Lilly Schilling Professorship (associate professor level)

2009

Fellow of the European Academy of Cancer Sciences

2011

7th A. Julio Martinez memorial lecture (University Pittsburgh)

2011

3rd Abhijit Guha Oration Award (Indian Society for Neurooncology)

2012

Dorothy Russel Medal (British Neuropathology Society)

2016

German Cancer Award (translational part)

2017

Fellow of the Leopoldina, the German National Academy of Sciences

2017

Fred W. Stewart Award (Memorial Sloane Kettering)

2019

Neuro-oncology Scientific Award of the American Academy of Neurology

Top